The Team2018-09-29T19:54:32+00:00

The Team

Orna Dreazen, Ph.d Dipl. BA
Chairperson of the Board

With a Ph.D. in Biochemistry from Weizmann Institute followed by post doctoral studies at UCLA and complemented by a diploma in Business administration from Tel-Aviv University, Dr. Dreazen has An illustrious career that encompassed senior positions in the public and private sectors. From pharmaceutical startups to senior roles in the Ministry of Health and Israel’s accreditation authority to substantial positions at international organizations. Dr. Dreazen is a world expert in Quality,  Metrology and product development.

Abraham Dreazen
CEO

Abraham Dreazen is an architect, entrepreneur and founder and CEO of Nextage Innovation. After building his career in NYC Abraham has joined Nextar chempharma solutions, Israel’s leading pharmaceutical CDMO to establish Nextage Innovation.

Marilyn A. Huestis
Professor Dr. Dr. (h.c.)
Head of advisory board

Professor Dr. Dr. (h.c.) Marilyn A. Huestis recently retired as a tenured senior investigator and Chief, Chemistry and Drug Metabolism Section, at NIDA, National Institutes of Health. She currently is a Senior Fellow at the Institute on Emerging Health Professions, Thomas Jefferson University and on the Steering Committee of The Lambert Center for the Study of Medicinal Cannabis and Hemp, Thomas Jefferson Medical School. Professor Hustis is the President of Huestis & Smith Toxicology, LLC.

The Team

Orna Dreazen, Ph.d Dipl. BA
Chairperson of the Board

With a Ph.D. in Biochemistry from Weizmann Institute followed by post doctoral studies at UCLA and complemented by a diploma in Business administration from Tel-Aviv University, Dr. Dreazen has An illustrious career that encompassed senior positions in the public and private sectors. From pharmaceutical startups to senior roles in the Ministry of Health and Israel’s accreditation authority to substantial positions at international organizations. Dr. Dreazen is a world expert in Quality,  Metrology and product development.

Orna Dreazen, Ph.d Dipl. BA
Chairperson of the Board

With a Ph.D. in Biochemistry from Weizmann Institute followed by post doctoral studies at UCLA and complemented by a diploma in Business administration from Tel-Aviv University, Dr. Dreazen has An illustrious career that encompassed senior positions in the public and private sectors. From pharmaceutical startups to senior roles in the Ministry of Health and Israel’s accreditation authority to substantial positions at international organizations. Dr. Dreazen is a world expert in Quality,  Metrology and product development.

Orna Dreazen, Ph.d Dipl. BA
Chairperson of the Board

With a Ph.D. in Biochemistry from Weizmann Institute followed by post doctoral studies at UCLA and complemented by a diploma in Business administration from Tel-Aviv University, Dr. Dreazen has An illustrious career that encompassed senior positions in the public and private sectors. From pharmaceutical startups to senior roles in the Ministry of Health and Israel’s accreditation authority to substantial positions at international organizations. Dr. Dreazen is a world expert in Quality,  Metrology and product development.

Orna Dreazen, Ph.d Dipl. BA
Chairperson of the Board

With a Ph.D. in Biochemistry from Weizmann Institute followed by post doctoral studies at UCLA and complemented by a diploma in Business administration from Tel-Aviv University, Dr. Dreazen has An illustrious career that encompassed senior positions in the public and private sectors. From pharmaceutical startups to senior roles in the Ministry of Health and Israel’s accreditation authority to substantial positions at international organizations. Dr. Dreazen is a world expert in Quality,  Metrology and product development.

Abraham Dreazen
CEO

Abraham Dreazen is an architect, entrepreneur and founder and CEO of Nextage Innovation. After building his career in NYC Abraham has joined Nextar chempharma solutions, Israel’s leading pharmaceutical CDMO to establish Nextage Innovation.

Marilyn A. Huestis
Professor Dr. Dr. (h.c.)
Head of advisory board

Professor Dr. Dr. (h.c.) Marilyn A. Huestis recently retired as a tenured senior investigator and Chief, Chemistry and Drug Metabolism Section, at NIDA, National Institutes of Health. She currently is a Senior Fellow at the Institute on Emerging Health Professions, Thomas Jefferson University and on the Steering Committee of The Lambert Center for the Study of Medicinal Cannabis and Hemp, Thomas Jefferson Medical School. Professor Hustis is the President of Huestis & Smith Toxicology, LLC.

Nextage Innovation Center

You are welcome to visit us at our offices to learn more

Contact us

If you need more information,
you can contact us:

Phone : 073-224-4440
Fax : 073-224-4445

Email :
info@NextageInnovation.com

Einstein St. Building 13B ,Weizmann Science Park
POB 4147 Ness Ziona 74140, Israel